Abstract
Background Patient assessment and documentation are less than optimal in pharmacy practice as preparing and dispensing medications is still a major part of community pharmacy practice. Pharmacists’ attitudes, specifically self-efficacy and role beliefs, toward practice have been shown to predict practice change. Objective This study will determine the impact of an interactive workshop on pharmacists’ attitudes toward assessment and documentation in routine pharmacy practice. Specific objectives included how (1) pharmacists’ role beliefs and self-efficacy toward assessment and documentation change after training and rehearsal and (2) frequently do pharmacists assess patient therapy and document patient care? Setting: “Chat, Check and Chart: patient assessment and documentation demystified” workshop Alberta College of Pharmacists Annual General Meeting in Calgary, Canada. Methods This study is pre–post evaluation. Quantitative data on self-efficacy and role beliefs toward assessment and documentation was gathered from a validated written survey. Surveys were completed before and after the intervention. The intervention, an interactive workshop, focused on the use of three tools practice and was designed to support pharmacists in achieving the assessment and documentation required by the Alberta College of Pharmacists Standards for Practice. Main outcome measure: Pharmacists’ role beliefs and self-efficacy toward assessment and documentation in patient care. Results Of the 61 eligible pharmacists, the response rate was 61 % (37 pharmacists) with complete data. In the past 2 weeks, 54 % of pharmacists were assessing patients and 32.6 % of pharmacists were documenting greater than half the time. Prior to the workshop, pharmacists “agreed” (5.42 ± 1.41) with their role in patient assessment and they were “quite sure” (4.75 ± 1.10) they could assess patients. Pharmacists “agreed” (5.13 ± 0.890) with their overall role in documentation of patient interactions and reported lower self-efficacy (3.88 ± 1.32) for their ability to document patient interactions. After the interactive workshop, there were statistically significant increases in pharmacists’ self-efficacy and role beliefs in regards to both patient assessment and documentation (p < 0.05). Conclusion This brief interactive workshop increased both self-efficacy and role beliefs towards assessment and documentation, indicating these pharmacists are likely to change future practice. Future research will assess practice uptake and implementation.
Similar content being viewed by others
References
Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42(7):1017–25.
Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE. 2009;4(2):e4439.
Samoy LJ, Zed PJ, Wilbur K, Balen RM, Abu-Laban RB, Roberts M. Drug-related hospitalizations in a tertiary care internal medicine service of a canadian hospital: a prospective study. Pharmacotherapy. 2006;26(11):1578–86.
Zed PJ, Abu-Laban RB, Balen RM, Loewen PS, Hohl CM, Brubacher JR, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ. 2008;178(12):1563–9.
Thinking outside the pillbox. A system-wide approach to improving patient medication adherence for chronic disease. Cambridge: New England Healthcare Institute; 2009.
Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001;41(2):192–9.
Avorn J, Shrank WH. Adverse drug reactions in elderly people: a substantial cause of preventable illness. BMJ. 2008;336(7650):956–7.
Thomsen LA, Winterstein AG, Sondergaard B, Haugbolle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother. 2007;41(9):1411–26.
Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int. 2010;5:391–8.
Yamada C, Johnson JA, Robertson P, Pearson G, Tsuyuki RT. Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus). Pharmacotherapy. 2005;25(1):110–5.
Tsuyuki RT, Olson KL, Dubyk AM, Schindel TJ, Johnson JA. Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus). Am J Med. 2004;116(2):130–3.
Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the study of cardiovascular risk intervention by pharmacists (SCRIP). Arch Intern Med. 2002;162(10):1149–55.
Roughead EE, Semple SJ, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes. Int J Pharm Pract. 2005;13:53–70.
Hughes CA, Guirguis LM, Wong T, Ng K, Ing L, Fisher K. Influence of pharmacy practice on community pharmacists’ integration of medication and lab value information from electronic health records. J Am Pharm Assoc. 2003;51(5):591–8.
Hughes CM, Hawwa AF, Scullin C, Anderson C, Bernsten CB, Bjornsdottir I, et al. Provision of pharmaceutical care by community pharmacists: a comparison across europe. Pharm World Sci. 2010;32(4):472–87.
Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy’s claims to professional status in the united kingdom. Res Soc Adm Pharm. 2009;5(4):305–18.
Jones EJ, MacKinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother. 2005;39(9):1527–33.
Bonfiglio MF, Lewis JD, Nesbit SA, Krinsky DL. A contemporary perspective on pharmacy’s traditional strengths. J Am Pharm Assoc. 1997;NS37(6):700–4.
Galt KA, Narducci WA. Integrated pharmaceutical care services: the product is part of the care. Pharmacotherapy. 1997;17(4):841–4.
Martinez Sanchez A, Campos RM. Detection of prescribing related problems at the community pharmacy. Int J Clin Pharm. 2011;33(1):66–9.
Braund R, Furlan HM, George K, Havell MM, Murphy JL, West MK. Interventions performed by new zealand community pharmacists while dispensing prescription medications. Pharm World Sci. 2010;32(1):22–5.
Ekedahl A. Problem prescriptions in Sweden necessitating contact with the prescriber before dispensing. Res Soc Adm Pharm. 2010;6(3):174–84.
Krahenbuhl JM, Kremer B, Guignard B, Bugnon O. Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharm World Sci. 2008;30(6):777–86.
Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):695–700.
Mandt I, Horn AM, Ekedahl A, Granas AG. Community pharmacists’ prescription intervention practices—Exploring variations in practice in Norwegian pharmacies. Res Soc Adm Pharm. 2010;6(1):6–17.
Deschamps M, Dyck A, Taylor J. What are we saying? Content and organization of patient counseling by community pharmacists. Can Pharm J. 2003;136(6):42–7.
Martin BA, Bruskiewitz RH, Chewning BA. Effect of a tobacco cessation continuing professional education program on pharmacists’ confidence, skills, and practice-change behaviors. J Am Pharm Assoc. 2003;50(1):9–16.
Schommer JC, Wiederholt JB. The association of prescription status, patient age, patient gender, and patient question asking behavior with the content of pharmacist-patient communication. Pharm Res. 1997;14(2):145–51.
Anonymous. Pharmacist-patient consultation program (PPCP-1): an interactive approach to patient consultation. New York, NY: Pfizer Inc.; 2002.
Berger BA. Communication skills for pharmacists: building relationships, improving care. Washington DC: American Pharmaceutical Association; 2009.
Beardsley RS, Kimberlin CL, Tindall WN. Communication skills in pharmacy practice. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
Cipolle RJ, Strand LM, Morley PC, Cipolle R, Strand L, Morley P. Pharmaceutical care practice: the clinician’s guide. 2nd ed. New York: McGraw-Hill Medical; 2004.
Farrell B, Kennie NR, Dolovich LR. Demonstrating value, documenting care: lessons learned about writing comprehensive patient medication assessments in the IMPACT project: part II. Can Pharm J. 2008;141(3):182–8.
Guirguis LM, Chewning BA. Development of a measure to assess pharmacy students’ beliefs about monitoring chronic diseases. Res Soc Adm Pharm. 2008;4(4):402–16.
Farris KB, Schopflocher DP. Between intention and behavior: an application of community pharmacists’ assessment of pharmaceutical care. Soc Sci Med. 1999;49(1):55–66.
Miller GE. The assessment of clinical skills/competence/performance. Acad Med. 1990;65(9 Suppl):S63–7.
Blake KB, Madhavan SS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother. 2010;44(3):424–31.
Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Building capacity to implement cognitive pharmaceutical services: quantifying the needs of community pharmacies. Res Soc Adm Pharm. 2010;6(3):163–73.
Bright DR, Lengel AJ, Powers MF. Pharmacists’ perceptions of barriers to implementing medication therapy management and the role of pharmacy technicians in overcoming the barriers. J Pharm Technol [Internet]. 2009;25:361–7.
Zardain E, del Valle MO, Loza MI, Garcia E, Lana A, Markham WA, et al. Psychosocial and behavioural determinants of the implementation of pharmaceutical care in Spain. Pharm World Sci. 2009;31(2):174–82.
McCaig D, Fitzgerald N, Stewart D. Provision of advice on alcohol use in community pharmacy: a cross-sectional survey of pharmacists’ practice, knowledge, views and confidence. Int J Pharm Pract. 2011;19(3):171–8.
Warholak TL, Rupp MT. Analysis of community chain pharmacists’ interventions on electronic prescriptions. J Am Pharm Assoc. 2003;49(1):59–64.
Lee I. Comparison of patients’ perceptions to pharmacists’ perceptions of pharmacy counseling. J Am Pharm Assoc. 2005;45(2):251.
Hirsch JD, Oen A, Robertson S, Nguyen N, Daniels C. Patient request for pharmacist counseling and satisfaction: automated prescription delivery system versus regular pick-up counter. J Am Pharm Assoc. 2003;49(1):73–7.
Chewning BA, Patwardhan PD. Ask, advise and refer: hypothesis generation to promote a brief tobacco-cessation intervention in community pharmacies. Int J Pharm Pract. 2009;17(9):221–9.
Floor-Schreudering A, De Smet PA, Buurma H, Egberts AC, Bouvy ML. Documentation quality in community pharmacy: completeness of electronic patient records after patients’ first visits. Ann Pharmacother. 2009;43(11):1787–94.
Brock KA, Casper KA, Green TR, Pedersen CA. Documentation of patient care services in a community pharmacy setting. J Am Pharm Assoc. 2006;46(3):378–84.
Angelo LB, Christensen DB, Ferreri SP. Impact of community pharmacy automation on workflow, workload, and patient interaction. J Am Pharm Assoc. 2005;45(2):138–44.
Acknowledgments
Anita Cumbleton and Andrew Wong, pharmacy students from the University of Alberta, Canada, were instrumental in conducting the research and analysis.
Funding
We would like to acknowledge the Alberta College of Pharmacists for supporting the training workshop.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guirguis, L.M., Lee, S. & Sanghera, R. Impact of an interactive workshop on community pharmacists’ beliefs toward patient care. Int J Clin Pharm 34, 460–467 (2012). https://doi.org/10.1007/s11096-012-9630-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-012-9630-6